Adam Keeney
Corporate Officer/Principal at BIOGEN INC.
Net worth: 148 910 $ as of 30/05/2024
Adam Keeney active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 16/04/2023 | - |
Career history of Adam Keeney
Former positions of Adam Keeney
| Companies | Position | Start | End |
|---|---|---|---|
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Director/Board Member | 23/09/2018 | - |
| Chief Executive Officer | 23/09/2018 | - | |
| President | 23/09/2018 | - |
Training of Adam Keeney
| The University of Nottingham | Doctorate Degree |
| University of Leeds | Undergraduate Degree |
Statistics
International
| United Kingdom | 4 |
| United States | 2 |
Operational
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| President | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Adam Keeney
- Experience